What does CUSIP 30315R107 represent in this 13F holders report?

CUSIP 30315R107 is the security identifier for FSTX - F-STAR THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held FSTX - F-STAR THERAPEUTICS INC - COM in Q4 2020?

19 institutional investors reported FSTX - F-STAR THERAPEUTICS INC - COM for Q4 2020. Use the holders table for investor-level position and value details.

F-STAR THERAPEUTICS INC - COM (FSTX)

CUSIP: 30315R107

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / COM
Total 13F shares: 1,432,931
Share change: +1,379,930
Total reported value: $14,143,000
Price per share: $9.87
Number of holders: 19
Value change: +$13,620,000
Number of buys: 18

Quarterly Holders Quick Answers

What is CUSIP 30315R107?
CUSIP 30315R107 identifies FSTX - F-STAR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021

Recent filing periods for CUSIP 30315R107:

Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021

Institutional Holders of F-STAR THERAPEUTICS INC - COM (FSTX) as of Q4 2020

As of 31 Dec 2020, F-STAR THERAPEUTICS INC - COM (FSTX) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,432,931 shares. The largest 10 holders included Atlas Venture Advisors, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Connolly Sarah T., BlackRock Inc., Novo Holdings A/S, BVF INC/IL, PARSONS CAPITAL MANAGEMENT INC/RI, Endurant Capital Management LP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.